Antimicrobial Agents and Chemotherapy, 2013-08, Vol.57 (8), p.3676-3680
2013
Details
- Autor(en) / Beteiligte
- Titel
- Clinical Validation of the Analysis of Linezolid and Clarithromycin in Oral Fluid of Patients with Multidrug-Resistant Tuberculosis
- Ist Teil von
- Antimicrobial Agents and Chemotherapy, 2013-08, Vol.57 (8), p.3676-3680
- Ort / Verlag
- Washington, DC: American Society for Microbiology
- Erscheinungsjahr
- 2013
- Link zum Volltext
- Quelle
- EZB Free E-Journals
- Beschreibungen/Notizen
- Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology. For an alternate route to AAC .asm.org, visit: AAC
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0066-4804eISSN: 1098-6596DOI: 10.1128/AAC.00558-13Titel-ID: cdi_pubmed_primary_23689722
- Format
- –
- Schlagworte
- Acetamides, Acetamides - blood, Acetamides - pharmacokinetics, Adult, Analytical Procedures, Antibiotics. Antiinfectious agents. Antiparasitic agents, Antitubercular Agents, Antitubercular Agents - pharmacokinetics, Area Under Curve, Bacterial diseases, Biological and medical sciences, Clarithromycin, Clarithromycin - analogs & derivatives, Clarithromycin - blood, Clarithromycin - pharmacokinetics, Confidence Intervals, Drug Monitoring, Drug Monitoring - methods, Female, Human bacterial diseases, Humans, Infectious diseases, Linezolid, Male, Medical sciences, Metabolic Clearance Rate, Mycobacterium, Oxazolidinones, Oxazolidinones - blood, Oxazolidinones - pharmacokinetics, Pharmacology. Drug treatments, Prospective Studies, Saliva - chemistry, Tuberculosis and atypical mycobacterial infections, Tuberculosis, Multidrug-Resistant, Tuberculosis, Multidrug-Resistant - drug therapy, Young Adult